430 related articles for article (PubMed ID: 28665351)
1. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
Hansen Q; Bachas C; Smit L; Cloos J
Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
[TBL] [Abstract][Full Text] [Related]
4. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
5. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy.
Kikushige Y
Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607
[TBL] [Abstract][Full Text] [Related]
6. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
Kikushige Y; Miyamoto T; Akashi K
Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
9. Recreating the Bone Marrow Microenvironment to Model Leukemic Stem Cell Quiescence.
O'Reilly E; Zeinabad HA; Nolan C; Sefy J; Williams T; Tarunina M; Hernandez D; Choo Y; Szegezdi E
Front Cell Dev Biol; 2021; 9():662868. PubMed ID: 34589478
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
[TBL] [Abstract][Full Text] [Related]
11. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.
Kikushige Y; Miyamoto T
Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150
[TBL] [Abstract][Full Text] [Related]
12. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
[TBL] [Abstract][Full Text] [Related]
13. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.
Chen Y; Li J; Xu L; Găman MA; Zou Z
Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119
[TBL] [Abstract][Full Text] [Related]
14. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
Pelosi E; Castelli G; Testa U
Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
[TBL] [Abstract][Full Text] [Related]
15. Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status.
Poohadsuan J; O'Doherty GA; Owattanapanich W; Kungwankiattichai S; Rojanasakul Y; Issaragrisil S; Luanpitpong S
Cell Commun Signal; 2023 Oct; 21(1):283. PubMed ID: 37828578
[TBL] [Abstract][Full Text] [Related]
16. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
Al-Mawali A; Gillis D; Lewis I
J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
[TBL] [Abstract][Full Text] [Related]
17. [Acute myeloid leukemia stem cells from genomic and immunological perspectives].
Goyama S
Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508
[TBL] [Abstract][Full Text] [Related]
18. Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia.
van Gils N; Denkers F; Smit L
Front Oncol; 2021; 11():659253. PubMed ID: 34012921
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
20. The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function.
Chung SS; Hu W; Park CY
Ther Adv Hematol; 2011 Oct; 2(5):317-34. PubMed ID: 23556099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]